Fig. 1
From: Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis
Overview of medication use by all 32 study participants shows no association with clinical improvement. P values from Fisher’s exact test (right) indicate statistical significance of association between MCII patient group and medication use/non-use at both visits. No significant association for any medication was found. bDMARDs, biologic disease-modifying anti-rheumatic drugs. csDMARDs, conventional synthetic disease-modifying anti-rheumatic drugs. MCII, minimum clinically important improvement. MCII+, patients who showed MCII. MCII−, patients who did not show MCII. N/A, not available